Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LiveSpo X-secret
- Development stage
- Unknown
- Lead developer
- LiveSpo Pharma
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Vaginal
01
Overview
LiveSpo X-secret is a vaginal spray probiotic suspension containing 5 billion CFU of three Bacillus strains: Bacillus subtilis, Bacillus clausii, and Bacillus coagulans. Developed by AnaBio Technologies, it is designed as a supportive treatment for vaginal infections, including vaginitis and sexually transmitted infections (STIs). The product functions by restoring the balance of the vaginal microbiota, inhibiting the growth of pathogenic bacteria, viruses, fungi, and protozoa, and regulating pro-inflammatory cytokines. The use of Bacillus spores provides enhanced stability in acidic and thermal environments compared to traditional Lactobacillus-based probiotics, and the spray delivery system is intended to offer a faster onset of action compared to oral or suppository formulations.
- Brand names
- LiveSpo X-secret
- Other names
- LiveSpo X-SECRET
Beyond the preview
Go deeper on LiveSpo X-secret.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LiveSpo X-secret.